Atypical Hyperplasia of the Breast clinical trials at UC Cancer
1 research study open to eligible people
open to all eligible people
This trial studies the implementation of web-based decision support tools for patients with atypical hyperplasia or lobular carcinoma in situ and healthcare providers. Decision support tools are designed to improve informed choice about breast cancer chemoprevention. Recognizing barriers and facilitators that can influence the adoption of decision support tools at recruitment centers may help researchers learn how to best implement them into clinical practice.
at UC Irvine
Our lead scientists for Atypical Hyperplasia of the Breast research studies include Erin H. Lin.